NCT06828159 Dietary Wild Blueberries and Joint Health
| NCT ID | NCT06828159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nevada, Las Vegas |
| Condition | Gut -Microbiota |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-09-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this proposed study is to examine the effects of dietary wild blueberries on gut microbiome, serum markers of inflammation, and joint function in adults. Each participant will consume 25g freeze-dried blueberries or matched placebo powder for 12 weeks, with a 2-week washout phase between.
Eligibility Criteria
Inclusion Criteria: * Adults with documented multi-joint/knee arthritis Exclusion Criteria: * inability to give informed consent * pregnancy or lactation * planned knee replacement surgery * allergy or contraindication to berries * recent trauma of the knee responsible of the symptomatic knee * intra-articular injection in the target knee/hip in the last 3 months * oral corticosteroid therapy ≥ 5 mg/day (prednisone equivalent) at baseline * use of berry extracts in the last 3 months * special diets * cancer treatment * bone diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06828159 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Gut -Microbiota. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06828159 currently recruiting?
Yes, NCT06828159 is actively recruiting participants. Contact the research team at arpita.basu@unlv.edu for enrollment information.
Where is the NCT06828159 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT06828159 clinical trial?
NCT06828159 is sponsored by University of Nevada, Las Vegas. The trial plans to enroll 50 participants.